Alfonso Garcia de Coca
Overview
Explore the profile of Alfonso Garcia de Coca including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
882
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Puertas B, Gonzalez-Calle V, Sobejano-Fuertes E, Escalante F, Queizan J, Barez A, et al.
Cancers (Basel)
. 2023 Mar;
15(5).
PMID: 36900349
(1) Background: New therapeutic strategies have improved the prognosis of multiple myeloma (MM), changing the accepted view of this disease from being incurable to treatable. (2) Methods: We studied 1001...
2.
Alameda D, Goicoechea I, Vicari M, Arriazu E, Nevone A, Rodriguez S, et al.
Blood
. 2021 Jun;
138(17):1583-1589.
PMID: 34133718
Although light-chain amyloidosis (AL) and multiple myeloma (MM) are characterized by tumor plasma cell (PC) expansion in bone marrow (BM), their clinical presentation differs. Previous attempts to identify unique pathogenic...
3.
Rodriguez-Otero P, Sirvent M, Gonzalez-Rodriguez A, Lavilla E, Garcia de Coca A, Arguinano J, et al.
Clin Lymphoma Myeloma Leuk
. 2021 Mar;
21(6):413-420.
PMID: 33741302
Introduction: Treatment of relapsed/refractory multiple myeloma (RRMM) is highly challenging, especially for patients with disease refractory to initial therapy, and in particular for disease developing refractoriness to lenalidomide. Indeed, with...
4.
Quijada-Alamo M, Perez-Carretero C, Hernandez-Sanchez M, Rodriguez-Vicente A, Herrero A, Hernandez-Sanchez J, et al.
Clin Transl Med
. 2021 Feb;
11(2):e304.
PMID: 33634999
Background: Several genetic alterations have been identified as driver events in chronic lymphocytic leukemia (CLL) pathogenesis and oncogenic evolution. Concurrent driver alterations usually coexist within the same tumoral clone, but...
5.
6q deletion in Waldenström macroglobulinaemia negatively affects time to transformation and survival
Garcia-Sanz R, Dogliotti I, Zaccaria G, Ocio E, Rubio A, Murillo I, et al.
Br J Haematol
. 2020 Aug;
192(5):843-852.
PMID: 32780894
Deletion of the long arm of chromosome 6 (del6q) is the most frequent cytogenetic abnormality in Waldenström macroglobulinaemia (WM), occurring in approximately 50% of patients. Its effect on patient outcome...
6.
Perez-Carretero C, Hernandez-Sanchez M, Gonzalez T, Quijada-Alamo M, Martin-Izquierdo M, Hernandez-Sanchez J, et al.
Int J Cancer
. 2020 Jul;
147(10):2780-2792.
PMID: 32720348
Chromosome 14q32 rearrangements/translocations involving the immunoglobulin heavy chain (IGH) are rarely detected in chronic lymphocytic leukemia (CLL). The prognostic significance of the IGH translocation is controversial and its mutational profile...
7.
Forero-Castro M, Montano A, Robledo C, Garcia de Coca A, Fuster J, de Las Heras N, et al.
Diagnostics (Basel)
. 2020 Jul;
10(7).
PMID: 32635531
The clonal basis of relapse in B-cell precursor acute lymphoblastic leukemia (BCP-ALL) is complex and not fully understood. Next-generation sequencing (NGS), array comparative genomic hybridization (aCGH), and multiplex ligation-dependent probe...
8.
Cuenca I, Alameda D, Sanchez-Vega B, Gomez-Sanchez D, Alignani D, Lasa M, et al.
Leukemia
. 2020 Mar;
35(1):245-249.
PMID: 32203144
No abstract available.
9.
Puig N, Paiva B, Lasa M, Burgos L, Perez J, Merino J, et al.
Leukemia
. 2018 Dec;
33(5):1256-1267.
PMID: 30542145
Early diagnosis and risk stratification are key to improve outcomes in light-chain (AL) amyloidosis. Here we used multidimensional-flow-cytometry (MFC) to characterize bone marrow (BM) plasma cells (PCs) from a series...
10.
Hernandez-Sanchez M, Kotaskova J, Rodriguez A, Radova L, Tamborero D, Abaigar M, et al.
Leukemia
. 2018 Sep;
33(2):518-558.
PMID: 30209402
No abstract available.